| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Gain on debt extinguishment | 0 | 0 | - | - |
| Total other (expense) income | -3,819 | 3,506 | 797 | 3,364 |
| Loss before income taxes | -72,673 | -9,283 | -13,282 | -145,182 |
| Net income (loss) attributable to parent, total | -72,673 | -9,283 | -13,282 | -145,182 |
| Net loss per share attributable to common stockholders, basic (in usd per share) | -1.36 | -0.18 | -0.26 | -2.9 |
| Net loss per share attributable to common stockholders, diluted (in usd per share) | -1.36 | -0.18 | -0.26 | -2.9 |
| Weighted-average common shares outstanding, basic (in shares) | 53,493,000 | 52,750,000 | 51,863,000 | 50,028,000 |
| Weighted-average common shares outstanding, diluted (in shares) | 53,493,000 | 52,750,000 | 51,863,000 | 50,028,000 |
Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)